Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $121,075 | 43 | 74.2% |
| Travel and Lodging | $22,682 | 36 | 13.9% |
| Consulting Fee | $14,646 | 7 | 9.0% |
| Food and Beverage | $4,784 | 66 | 2.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $139,083 | 125 | $0 (2024) |
| Genentech USA, Inc. | $21,655 | 20 | $0 (2020) |
| PFIZER INC. | $1,110 | 1 | $0 (2023) |
| Boehringer Ingelheim International GmbH | $889.71 | 2 | $0 (2021) |
| Partner Therapeutics, Inc. | $400.00 | 1 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $19.23 | 1 | $0 (2021) |
| GENZYME CORPORATION | $15.81 | 1 | $0 (2021) |
| Takeda Pharmaceuticals U.S.A., Inc. | $14.65 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $18,419 | 15 | Boehringer Ingelheim Pharmaceuticals, Inc. ($18,019) |
| 2023 | $22,799 | 13 | Boehringer Ingelheim Pharmaceuticals, Inc. ($21,689) |
| 2022 | $13,553 | 5 | Boehringer Ingelheim Pharmaceuticals, Inc. ($13,553) |
| 2021 | $26,269 | 26 | Boehringer Ingelheim Pharmaceuticals, Inc. ($25,330) |
| 2020 | $12,884 | 8 | Boehringer Ingelheim Pharmaceuticals, Inc. ($6,651) |
| 2019 | $37,759 | 35 | Boehringer Ingelheim Pharmaceuticals, Inc. ($22,589) |
| 2018 | $18,130 | 21 | Boehringer Ingelheim Pharmaceuticals, Inc. ($18,002) |
| 2017 | $13,374 | 29 | Boehringer Ingelheim Pharmaceuticals, Inc. ($13,249) |
All Payment Transactions
152 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Travel and Lodging | In-kind items and services | $101.83 | General |
| 12/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $26.97 | General |
| 12/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $24.65 | General |
| 11/08/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,615.00 | General |
| 11/08/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,615.00 | General |
| 11/08/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,307.50 | General |
| 10/10/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Travel and Lodging | In-kind items and services | $646.26 | General |
| 10/10/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $46.04 | General |
| 10/10/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $23.85 | General |
| 10/09/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Travel and Lodging | In-kind items and services | $2,190.02 | General |
| 10/09/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Travel and Lodging | In-kind items and services | $425.75 | General |
| 10/09/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $124.86 | General |
| 06/03/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,770.00 | General |
| 05/09/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $101.55 | General |
| 05/02/2024 | Partner Therapeutics, Inc. | LEUKINE (Drug) | Consulting Fee | Cash or cash equivalent | $400.00 | General |
| Category: Hematology/Oncology | ||||||
| 10/20/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,770.00 | General |
| 09/12/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $111.57 | General |
| 08/16/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,615.00 | General |
| 07/25/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,615.00 | General |
| 07/25/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,615.00 | General |
| 07/18/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Travel and Lodging | In-kind items and services | $66.00 | General |
| 07/18/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $7.97 | General |
| 06/29/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $124.99 | General |
| 06/29/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $23.01 | General |
| 06/28/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Travel and Lodging | In-kind items and services | $3,982.79 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 1,783 | 2,066 | $476,381 | $53,923 |
| 2022 | 11 | 1,953 | 2,266 | $431,447 | $54,547 |
| 2021 | 13 | 1,967 | 2,312 | $538,661 | $74,835 |
| 2020 | 13 | 1,429 | 1,689 | $513,374 | $65,230 |
All Medicare Procedures & Services
68 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 56 | 121 | $200,739 | $19,817 | 9.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 66 | 105 | $43,995 | $6,878 | 15.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 55 | 73 | $30,467 | $4,580 | 15.0% |
| 94010 | Test to measure expiratory airflow and volume | Facility | 2023 | 658 | 776 | $49,664 | $4,512 | 9.1% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 466 | 477 | $32,913 | $3,074 | 9.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 20 | 25 | $14,605 | $2,446 | 16.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 18 | 18 | $12,555 | $1,844 | 14.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 35 | 43 | $11,696 | $1,774 | 15.2% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 246 | 253 | $25,806 | $1,772 | 6.9% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 16 | 19 | $11,552 | $1,741 | 15.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 13 | 16 | $9,456 | $1,435 | 15.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 19 | 23 | $9,752 | $1,401 | 14.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 14 | 14 | $10,332 | $1,303 | 12.6% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2023 | 86 | 86 | $8,342 | $736.13 | 8.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 15 | 17 | $4,507 | $608.28 | 13.5% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 48 | 103 | $155,324 | $17,425 | 11.2% |
| 94010 | Test to measure expiratory airflow and volume | Facility | 2022 | 715 | 871 | $50,542 | $5,170 | 10.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 50 | 69 | $26,201 | $4,713 | 18.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 29 | 38 | $20,406 | $3,974 | 19.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 50 | 59 | $22,303 | $3,899 | 17.5% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2022 | 537 | 556 | $35,028 | $3,607 | 10.3% |
| 99292 | Critical care, each additional 30 minutes | Facility | 2022 | 15 | 30 | $22,620 | $2,575 | 11.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 21 | 24 | $12,888 | $2,489 | 19.3% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 22 | 34 | $18,802 | $2,484 | 13.2% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2022 | 266 | 277 | $25,761 | $2,003 | 7.8% |
About Dr. Leslie Tolle, M.D
Dr. Leslie Tolle, M.D is a Internal Medicine healthcare provider based in Cleveland, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/06/2007. The National Provider Identifier (NPI) number assigned to this provider is 1104948231.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Leslie Tolle, M.D has received a total of $163,187 in payments from pharmaceutical and medical device companies, with $18,419 received in 2024. These payments were reported across 152 transactions from 8 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($121,075).
As a Medicare-enrolled provider, Tolle has provided services to 7,132 Medicare beneficiaries, totaling 8,333 services with total Medicare billing of $248,534. Data is available for 4 years (2020–2023), covering 68 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Pulmonary Disease, Critical Care Medicine
- Location Cleveland, OH
- Active Since 04/06/2007
- Last Updated 07/17/2013
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1104948231
Products in Payments
- OFEV (Drug) $17,649
- LEUKINE (Drug) $400.00
- Esbriet (Biological) $396.02
- DUPIXENT (Biological) $35.04
- CUVITRU (Biological) $14.65
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Cleveland
C Martin Harris, Md, MD
Internal Medicine — Payments: $1.1M
Marina Magrey, Md, MD
Internal Medicine — Payments: $491,321
Dr. Moshe Ornstein, Md Ma, MD MA
Internal Medicine — Payments: $250,140
Dr. Katherine Talcott, M.d, M.D
Internal Medicine — Payments: $248,994
Dr. Elliott Dasenbrook, Md, MD
Internal Medicine — Payments: $184,924
Syed Bukhari
Internal Medicine — Payments: $164,516